Session » Systemic Lupus Erythematosus – Human Etiology and Pathogenesis - Poster I
- 9:00AM-11:00AM
-
Abstract Number: 1840
A Dichotomy of Regulatory Immunome Is Related to Disease Activity in Juvenile Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1831
A Novel Graph Theoretic Approach Applied to Modular Repertoire Analysis Identifies a Dual Molecular Progression in Adult SLE Patients, with Distinct Interferon and Neutrophil Transcription Patterns
- 9:00AM-11:00AM
-
Abstract Number: 1823
African American and European American SLE Patients with Variable Disease Activity Reveal Distinct Differences in CD4+ T Cell and Monocyte Pathways
- 9:00AM-11:00AM
-
Abstract Number: 1838
Antibodies Against Bacterial Products Curli/DNA Are Found in Lupus Patients and Are Associated with Disease Flares
- 9:00AM-11:00AM
-
Abstract Number: 1833
Autoantibody Response to TROVE2 in Systemic LUPUS Erythematosus Patients
- 9:00AM-11:00AM
-
Abstract Number: 1822
CD4+ T Cell Lymphopenia Is Associated with Deficient Ubiquitination of the Cell Cycle Inhibibitor p27kip1 By the E3 Ligase Casitas B-Lineage Lymphoma-b in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1834
Commensal Ro60 Autoantigen Ortholog Cross-Reactivity in Human Lupus and Gnotobiotic Models
- 9:00AM-11:00AM
-
Abstract Number: 1820
Dectin-1 on Monocytic Cells Mediates Aberrant Innate and Adaptive Immune Responses in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1821
Demethylated CD4+CD28+KIR+CD11ahi T Cells Are Characterized By a Pro-Inflammatory Transcriptome and Interact with Genetic Risk to Predict Disease Activity in Lupus
- 9:00AM-11:00AM
-
Abstract Number: 1841
Dysregulation of the Splicing Machinery Components in Leukocytes from Patients with Systemic Lupus Erythematosus: Influence on Autoimmune and Atherothrombotic Mechanisms
- 9:00AM-11:00AM
-
Abstract Number: 1839
Elevated Plasma Cell-Free Mitochondrial DNA Defines a Subgroup of Lupus Patients with Membranous Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 1837
Genetic Susceptibility Loci for Systemic Lupus Erythematosus in the Dominican Republic Population
- 9:00AM-11:00AM
-
Abstract Number: 1829
Hyper-Responsiveness to TLR-4 Stimulation in SLE: Association with High Levels of Serum IFN-Alpha and a Distinct Inflammatory Cytokine Profile
- 9:00AM-11:00AM
-
Abstract Number: 1832
Increased Interferon b Expression in Bone Marrow Mediates a Senescent Phenotype and Impaired Production of Immunomodulatory Factors By SLE Mesenchymal Stromal Cells
- 9:00AM-11:00AM
-
Abstract Number: 1844
Mesenchymal Stem Cells Ameliorate the Deficiencies in Immunomodulatory and Phagocytic Capacities of Lupus Macrophages
- 9:00AM-11:00AM
-
Abstract Number: 1828
Metabolic Reprogramming in CD4+CD28-CXCR3intt-bethi cells and Its Relevance to Pathogenesis in Patients with SLE
- 9:00AM-11:00AM
-
Abstract Number: 1824
Mycophenolate Mofetil Use Associates with Unique Biologic Changes in B Cell and T Regulatory Cell Pathways in SLE Patients
- 9:00AM-11:00AM
-
Abstract Number: 1842
Pentraxin 3 Level Positively Correlated with Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus Patients
- 9:00AM-11:00AM
-
Abstract Number: 1843
Single Cell Expression Quantitative Trait Loci (eQTL) Analysis of Established SLE-Risk Loci in Lupus Patient Monocytes
- 9:00AM-11:00AM
-
Abstract Number: 1836
SLE Bone Marrow Contains Factors That Promote Type I Interferon Activation
- 9:00AM-11:00AM
-
Abstract Number: 1826
STAT3 Phosphorylation Mediates the Stimulatory Effects of Interferon Alpha on B Cell Differentiation and Activation in SLE
- 9:00AM-11:00AM
-
Abstract Number: 1835
Study on the Expression of NOD2 in Lupus Nephritis and Its Potential Signaling Pathway
- 9:00AM-11:00AM
-
Abstract Number: 1825
the Non-Coding Genome and the Genetics of Systemic Lupus
- 9:00AM-11:00AM
-
Abstract Number: 1830
The Role of Tripartite Motif-Containing 21 in Interferon Signature of Systemic Lupus Erythematosus